1 |
M. L. Williams, D. L. Rimm, M. A. Pedigo, and W. J. Frable, "Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from a academic medical center," Diagn Cytopathol, Vol.16, pp.1-7, 1997.
DOI
|
2 |
K. W. Alanen, L. M. Elit, P. A. Molinaro, and C. M. McLachlin, "Accesment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesion," Cancer, Vol.84, pp.5-10, 1988.
|
3 |
K. A. Dvorak, M. Finnemore, and J. A. Mksem, "Histology correlation with atypical squamous cells of undetermined significance(ASCUS) or low grade squamous intraepithelial lesion(LSIL) cytology diagnosis: an argument to ensure ASCUS follow-up that is as aggressive as that for LSIL," Diagn Cytopathol, Vol.21, pp.292-295, 1999.
DOI
ScienceOn
|
4 |
I. Nindil, A. Lorincz, I. Mielzynska, U. Petry, S. Baur, R. Kirchmayr, W. Michels, and A. Schneider, "Human papilloma virus detection in cervical intraneoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods," Clin Diagn Virol, Vol.10, pp.49-56, 1998.
DOI
ScienceOn
|
5 |
T. C. Wright, X. W. Sun, and J. Koulos, "Comparision of management algorythms for the evaluation of women with low-grade cytologic abnormalities," Obstet Gynecol, Vol.85, pp.202-210, 1995.
DOI
ScienceOn
|
6 |
C. Perrons, R. Jelley, B. Klete, W. Quint, and N. Brink, "Detection of persistent high risk human papilloma virus injections with hybrid capture II and SPF10/LiPA, J Clin Virol, Vol.32, pp.278-285, 2005.
DOI
ScienceOn
|
7 |
World Health Organization, "WHO position on HPV vaccines," Vaccine, Vol.27, pp.7236-7237, 2009.
DOI
ScienceOn
|
8 |
N. Munoz, F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. Shah, and P. J. Snijders, "Epidermiologic classification of human papillomavirus types associated with cervical cancer," N Engl J Med, Vol.348, pp.518-527, 2003.
DOI
ScienceOn
|
9 |
A. Schneider, "Cervical and vaginal HPV infections," Clin Dermatol, Vol.15, pp.389-398, 1997.
DOI
ScienceOn
|
10 |
C. S. Herrington, M. F. Evans, W. Gray, and J. O. D. McGee, "Morphological correlation of human papilloma virus infection of matched cervical smears and bioscopes from patients with persistant mild cervical cytological abnorminalities," Human Pathol, Vol.26, pp.951-955, 1995.
DOI
ScienceOn
|
11 |
L. C. R. Tewari, and C. A. Chaudhary, "Atypical squamous cells of undetermined significance, a follow up study," MJAFI, Vol.66, pp.225-227, 2010.
|
12 |
R. Kurman, and D. Solomon, "The bethesda system for reporting cervical/vaginal cytologic diagnosis: definitions, criteria and explanatory notes for terminology and specimen adequacy," New York, Springer Verlag, pp.148-156, 1994.
|
13 |
F. X. Bosch, M. M. Manos, and N. Munoz, "Prevalence of human papilloma virus in cervical cancer: a worldwide perspective," J Natl Cancer Inst, Vol.87, pp.796-802, 1995.
DOI
ScienceOn
|
14 |
M. del Pino, L. Rodriguez-Carunchio, I. Alonso, A. Torne, A. Rodriguez, P. Fuste, P. Castillo, N. Nonell, N. Abu-Lhiga, and J. Ordi, "Clinical, colposcopic and pathological charateristics of cervical and vaginal high-grade negative for HPV by Hybrid Capture 2," Gynecol Oncol, Vol.122, pp.515-520, 2011.
DOI
ScienceOn
|